Literature DB >> 1384852

Reduction of CSF monoamine metabolites in poststroke depression: a preliminary report.

J B Bryer1, S E Starkstein, V Votypka, R M Parikh, T R Price, R G Robinson.   

Abstract

Monoamine metabolites were measured in the cerebrospinal fluid (CSF) of depressed and nondepressed patients with acute stroke lesions and in nondepressed patients without stroke lesions. Depressed stroke patients had a significantly lower concentration of CSF 5-hydroxyindoleacetic acid (5-HIAA; a serotonin metabolite) than the other two groups. These findings suggest that poststroke depression may be mediated by serotonergic mechanisms.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384852     DOI: 10.1176/jnp.4.4.440

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  8 in total

Review 1.  Neuroprotective effect of atypical antipsychotics in cognitive and non-cognitive behavioral impairment in animal models.

Authors:  Jue He; Jiming Kong; Qing-Rong Tan; Xin-Min Li
Journal:  Cell Adh Migr       Date:  2009-01-13       Impact factor: 3.405

Review 2.  The neuroanatomical model of post-stroke depression: towards a change of focus?

Authors:  Micaela Santos; Enikö Kövari; Gabriel Gold; Vasilis P Bozikas; Patrick R Hof; Constantin Bouras; Panteleimon Giannakopoulos
Journal:  J Neurol Sci       Date:  2009-03-04       Impact factor: 3.181

Review 3.  Association between homocysteine levels in acute stroke and poststroke depression: A systematic review and meta-analysis.

Authors:  Yupei Chen; Hua Zou; Meidi Peng; Yan Chen
Journal:  Brain Behav       Date:  2022-05-23       Impact factor: 3.405

4.  Methylphenidate modulates activity within cognitive neural networks of patients with post-stroke major depression: A placebo-controlled fMRI study.

Authors:  Rajamannar Ramasubbu; Bradley G Goodyear
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

Review 5.  The role of neuroinflammation and neurovascular dysfunction in major depressive disorder.

Authors:  Sang Won Jeon; Yong-Ku Kim
Journal:  J Inflamm Res       Date:  2018-05-08

6.  Efficacy and tolerability of pharmacotherapy for post-stroke depression: a network meta-analysis.

Authors:  Linghui Deng; Shi Qiu; Yan Yang; Lu Wang; Yuxiao Li; Jing Lin; Qiang Wei; Lu Yang; Deren Wang; Ming Liu
Journal:  Oncotarget       Date:  2018-01-03

Review 7.  Poststroke Depression Biomarkers: A Narrative Review.

Authors:  Oleg A Levada; Alexandra S Troyan
Journal:  Front Neurol       Date:  2018-07-16       Impact factor: 4.003

Review 8.  Diversiform Etiologies for Post-stroke Depression.

Authors:  Zan Wang; Yanmin Shi; Fangfang Liu; Nan Jia; Junya Gao; Xiaomin Pang; Fang Deng
Journal:  Front Psychiatry       Date:  2019-01-23       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.